Previous close | 2.1000 |
Open | 2.0700 |
Bid | 2.0700 x 300 |
Ask | 2.1000 x 400 |
Day's range | 2.0500 - 2.1550 |
52-week range | 1.3200 - 3.4100 |
Volume | |
Avg. volume | 781,370 |
Market cap | 534.088M |
Beta (5Y monthly) | -0.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Lyell Immunopharma ( NASDAQ:LYEL ) First Quarter 2024 Results Key Financial Results Net loss: US$60.7m (loss narrowed...
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.